In recent years, the development of the pharmaceutical industry has encountered many difficulties, but the "plant extract industry", whether for export or domestic sales, has gradually become the fastest growing industry in the traditional Chinese medicine industry. According to the customs data, the export volume of China's plant extract industry in 2002 was only US $200 million, and by 2011 it had exceeded US $1 billion, reaching US $1.13 billion. In 2014, China's export of plant extracts jumped to 1.778 billion US dollars, with a year-on-year growth of 25.88%, and the development speed was fast.
In the early 1980s, Europe and the United States and other developed countries set off an upsurge of returning to nature. People paid more attention to the artificial compound products with side effects, and turned to the pursuit of natural and safe plant extracts. In 1994, the United States promulgated the dietary supplement health and Education Act, which formally recognized the use of plant extracts as a food supplement. Germany was in the legislative process Plant extracts are allowed to be registered as prescription drugs in the European Pharmacopoeia. The European Pharmacopoeia puts forward the general rules of extracts, and classifies the quality standards of plant extracts and purified extracts.
Among them, our products exported to the United States are mainly used for dietary supplements and food additives. The plant extracts from Japan are mainly used for the production of health food and Chinese herbal medicines. The products exported to India are mainly natural pigments and flavors and fragrances. The export to Korea is mainly the products of health care plant extracts, and the export to Germany is mainly medicinal plants such as Rutin.
Post time: Apr-05-2021
